Boanmycin hydrochloride

盐酸博安霉素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBoanmycin hydrochloride
Drug Alias NameBoanmycin业立宁艾普康
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCells inhibitors
TargetsNot applicable
Therapy Area/IndicationsHead and Neck NeoplasmsLiver NeoplasmsEsophageal Neoplasms +[4] 
Global Approved IndicationsHead and Neck Neoplasms
Approved Indications in ChinaHead and Neck Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2004/06/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesInstitute Of Medical Biology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Taihe Pharmaceutical Co LtdLiaoyuan Di Kang Pharmaceutical Limited Liability Company
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsLiver NeoplasmsEsophageal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL01XX
Related LinksN/A